ART5 is designed to address the most common root cause of ADPKD by targeting PKD1, potentially restoring PC1 production in approximately 85% of patientsFirst-in-human SAD study in healthy volunteers ...

About one in every 25 Australians under the age of 18 has been the victim or knows a victim of artificial ...

Adisa Blessing Oluwafikayo, a First-Class UNILORIN Maths graduate, gains national attention after securing a fully funded ...

The compact car segment is where reliability matters most to the budget-minded buyer, and the Toyota Corolla, Honda Civic, ...

Dr. Laws, former immunology leader at Sanofi, will oversee global development of Kymera’s KT-621 program. KT-621 parallel Phase 2b trials advancing in AD and asthma, with data e ...

An IIT Bombay study suggests print-and-digital learning may lower cognitive load, enhancing student engagement and retention.

(Guido Mieth/Getty Images) Cheap daily supplements are changing how scientists view the gut and its connection to the brain.

Divarasib outperformed existing therapies in patients with KRAS G12C non-small cell lung cancer (NSCLC).

Elite Scythians such as the “Golden Man” inherited their lofty status and shared power during the Iron Age, DNA analysis ...

Neurocrine Biosciences, Inc. stays a Buy as Ingrezza, Crenessity, and Vykat drive 44% revenue growth; see valuation, patents ...

When Harsha Koorimannil Valiyamannil made the decision to leave her home in Kerala, southern India, and move to Belfast to study Computing Science at Ulster University, she knew she was embarking on a ...

Incyte (Nasdaq:INCY) announced today it has completed its acquisition of Vega Therapeutics, Inc., a wholly owned subsidiary of Star Therapeutics LLC. The acquisition adds VGA039, a novel monoclonal ...